Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.22
- Piotroski Score 3.00
- Grade Buy
- Symbol (ENOV)
- Company Enovis Corporation
- Price $43.66
- Changes Percentage (0.66%)
- Change $0.29
- Day Low $43.58
- Day High $45.15
- Year High $65.03
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $65.50
- High Stock Price Target $70.00
- Low Stock Price Target $62.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.90
- Trailing P/E Ratio -24.39
- Forward P/E Ratio -24.39
- P/E Growth -24.39
- Net Income $-33,261,000
Income Statement
Quarterly
Annual
Latest News of ENOV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The future is Bryte: West Sacramento park renovations a go thanks to neighbor advocacy, new federal funding
Bryte Park in West Sacramento is set to undergo a $30 million makeover with federal, state, and local funding. Neighbors' persistence and advocacy led to the revival of the park, including plans for a...
By CBS News | 15 hours ago -
Cenovus Energy (CVE): Hedge Funds Are Bullish On This Undervalued Canadian Stock Now
An overview of the Canadian economic outlook and Cenovus Energy's position among undervalued stocks is discussed. The growth prospects for Canada's economy, investment insights from Warren Buffett, an...
By Yahoo! Finance | 2 days ago -
Cenovus Energy (TSX:CVE) Reports Strong Q2 Earnings and Dividend Increase, Highlights Growth Potential
Cenovus Energy has achieved a net debt target of $4 billion and plans to return excess funds to shareholders. Despite operational challenges in its downstream segment, the company maintains strong fin...
By Yahoo! Finance | 1 week ago
